Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Biopharma Biotech Business Development
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Commercialization Consulting Resource Center
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
Biopharma Biotech Clinical trials
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Biopharma Biotech Clinical trials
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Blog February 24, 2026
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Biopharma Biotech Clinical trials
Key market access considerations for long-acting and alternative delivery therapies Key market access considerations for long-acting and alternative delivery therapies
Blog February 20, 2026
Key market access considerations for long-acting and alternative delivery therapies
Biopharma Commercialization FDA
The market access “sweet spots” where payers reimburse more convenient therapies The market access “sweet spots” where payers reimburse more convenient therapies
Blog February 19, 2026
The market access “sweet spots” where payers reimburse more convenient therapies
Biopharma Commercialization Consulting Resource Center

Biopharma

Understanding the epidemiology of SMA Understanding the epidemiology of SMA
Blog December 18, 2025
Understanding the epidemiology of SMA
Forecasting target markets using epidemiology data: how Clarivate does it Forecasting target markets using epidemiology data: how Clarivate does it
Blog December 8, 2025
Forecasting target markets using epidemiology data: how Clarivate does it
Machine curation in action: a new approach to essential tremor epidemiology Machine curation in action: a new approach to essential tremor epidemiology
Blog November 17, 2025
Machine curation in action: a new approach to essential tremor epidemiology
Seven companies forging new paths in women’s health Seven companies forging new paths in women’s health
Blog November 13, 2025
Seven companies forging new paths in women’s health
Six companies enabling precision interventions for “undruggable” targets Six companies enabling precision interventions for “undruggable” targets
Blog October 7, 2025
Six companies enabling precision interventions for “undruggable” targets
GLP-1 weight loss access comes down to a dogfight in the U.S. GLP-1 weight loss access comes down to a dogfight in the U.S.
Blog October 3, 2025
GLP-1 weight loss access comes down to a dogfight in the U.S.
How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship
Blog September 22, 2025
How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship
BioWorld at 35: a legacy of trusted journalism, a future of innovation BioWorld at 35: a legacy of trusted journalism, a future of innovation
Blog September 17, 2025
BioWorld at 35: a legacy of trusted journalism, a future of innovation
How creative design can elevate your healthcare value communication tools How creative design can elevate your healthcare value communication tools
Blog September 12, 2025
How creative design can elevate your healthcare value communication tools
5 key time-saving benefits of AI-driven regulatory intelligence 5 key time-saving benefits of AI-driven regulatory intelligence
Blog September 10, 2025
5 key time-saving benefits of AI-driven regulatory intelligence